RISK-FACTORS FOR THE DEVELOPMENT OF AUDITORY TOXICITY IN PATIENTS RECEIVING AMINOGLYCOSIDES

被引:183
作者
MOORE, RD
SMITH, CR
LIETMAN, PS
机构
[1] JOHNS HOPKINS UNIV, DEPT MED, DIV INTERNAL MED, BALTIMORE, MD 21218 USA
[2] JOHNS HOPKINS UNIV, DEPT MED, DIV CLIN PHARMACOL, BALTIMORE, MD 21218 USA
[3] JOHNS HOPKINS UNIV, DEPT PHARMACOL & EXPTL THERAPEUT, BALTIMORE, MD 21218 USA
关键词
D O I
10.1093/infdis/149.1.23
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:23 / 30
页数:8
相关论文
共 33 条
[1]  
BALLANTYNE J, 1973, AUDIOLOGY, V12, P325
[3]   TOBRAMYCIN SULFATE - SUMMARY OF WORLDWIDE EXPERIENCE FROM CLINICAL-TRIALS [J].
BENDUSH, CL ;
WEBER, R .
JOURNAL OF INFECTIOUS DISEASES, 1976, 134 :S219-S234
[4]  
BENDUSH CL, 1982, AMINOGLYCOSIDES MICR, V21, P453
[5]   DEAFNESS COMPLICATING ANTIBIOTIC THERAPY OF HEPATIC ENCEPHALOPATHY [J].
BERK, DP ;
CHALMERS, T .
ANNALS OF INTERNAL MEDICINE, 1970, 73 (03) :393-+
[6]  
BLACK RE, 1976, ANTIMICROB AGENTS CH, V9, P956, DOI 10.1128/AAC.9.6.956
[7]  
BRUMMETT RE, 1981, REV INFECT DIS, V3, pS216
[8]  
BRUMMETT RE, 1978, J ANTIMICROB CHEMOTH, V4, P73, DOI 10.1093/jac/4.suppl_A.73
[9]  
CABRERA J, 1982, GASTROENTEROLOGY, V82, P97
[10]   GENTAMICIN THERAPY IN RENAL-FAILURE - NOMOGRAM FOR DOSAGE [J].
CHAN, RA ;
BENNER, EJ ;
HOEPRICH, PD .
ANNALS OF INTERNAL MEDICINE, 1972, 76 (05) :773-+